Citius pharmaceuticals to join benzinga all access show on friday, september 17, 2021

Cranford, n.j., sept. 14, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products and stem cell therapies, today announced that it will be joining benzinga's all access show for a 20-minute interview on friday, september 17, 2021 at 10:10 am et.
CTXR Ratings Summary
CTXR Quant Ranking